Week in Review: Keeping Patients In-The-Know
By Christian Clymer | February 27, 2015
Many patients are not aware of the harmful effects that non-adherence to needed medicines can have on their health, lifestyle and the economy. This week, we explored the ways in which medication...
Read More
U.S. Trade Representative Continues the Vital IP Dialogue
By Jay Taylor | February 24, 2015
Understanding how intrinsic intellectual property (IP) is to the United States economy (innovative industries support more than a quarter of all jobs in the U.S.), the Office of the U.S. Trade...
Read More
Medicare Monday: Medicare Part D & Adherence Help High Cholesterol Patients Save
By Allyson Funk | February 23, 2015
According to the Centers for Disease Control and Prevention, one in three American adults has high cholesterol. For those struggling with high cholesterol, getting needed prescriptions and...
Read More
India—Seizing the Opportunity
By Bill Chin, M.D. | February 19, 2015
I am excited to be in India this week to discuss the scientific landscape of pharmaceutical research and development. Everywhere I go I see so much potential for India to become a leader in the...
Read More
PhRMA Foundation Launches New Web Platform
By Eileen Cannon | February 18, 2015
For 50 years, the PhRMA Foundation has supported young scientists in their efforts to pursue careers in research and education that will ultimately lead to improved care and treatment options for...
Read More
Medicare Monday: Managing Diabetes Thanks to Medicare Part D
By Allyson Funk | February 16, 2015
Managing diabetes treatments is a big task. Medicare Part D helps patients access needed medicines, keeps costs low and helps avoid costly hospitalizations and complications. According to Betty,...
Read More
Week in Review: Vaccine Myth Busters Edition
By Christian Clymer | February 13, 2015
The internet provides us with a wealth of information right at our fingertips, but it’s important to be mindful of misinformation, especially as it pertains to your health. With myths and facts...
Read More
Health Insurance Exchange Plans Increasingly Putting Needed Medicines Out of Reach
By Allyson Funk | February 11, 2015
Last year, PhRMA was joined by patient groups to highlight an analysis that found a majority of plans in health insurance exchanges required relatively high cost sharing for all medicines in at...
Read More
PhRMA Salutes Outgoing FDA Commissioner’s Leadership, Looks Forward to Continued Collaboration
By Bill Chin, M.D. | February 10, 2015
Last week, Food and Drug Administration (FDA) Commissioner Margaret Hamburg announced that she will step down from her post at the end of next month.
Read More
Medicare Monday: Congestive Heart Failure Patients Benefit From Taking Advantage of Part D
By Allyson Funk | February 9, 2015
When a Medicare Part D beneficiary adheres to their prescription regimen, both the individual and the broader health care system benefit. The Congressional Budget Office (CBO), for example, now...
Read More
According to a new report from actuaries Gabriela Dieguez, Bruce Pyenson and Jennifer Carioto, at Milliman, major pharmacy benefits managers (PBMs) often overestimate future spending on specialty...
Read More
Week in Review: Continued Progress for Patient Health
By Christian Clymer | February 6, 2015
In recent years, the development of new medicines has helped transform the lives of patients. But lives cannot be improved without access to those innovative treatments. We support helping...
Read More
New Analysis: Midyear Formulary Changes in Marketplace Plans Can Significantly Reduce Access to Needed Medications for Patients
By Karyn Schwartz | February 5, 2015
Did you know health insurance exchange plans are allowed to drop coverage of medications from their formularies midyear? Early evidence indicates that some health insurance exchange or marketplace...
Read More
World Cancer Day: Revolutionizing Treatment for Patients is “Not Beyond Us”
By Tina Stow | February 4, 2015
Today is World Cancer Day, and 2015’s “Not beyond us” theme highlights an incredibly important message: we’re making tremendous advances in the fight against cancer and continued progress means a...
Read More
Maintaining Appropriate Incentives for Biopharmaceutical Innovation
By Anne McDonald Pritchett, PhD | February 4, 2015
As we enter the second half of the decade, the biopharmaceutical industry’s approach to research and development (R&D) continues to evolve to meet the growing demand for new medicines. New...
Read More
Why the World Looks to the U.S. for the Most Elusive Cures
By Robert Zirkelbach | February 3, 2015
Research and development (R&D) is the backbone of the biopharmaceutical industry and the reason why we have seen more than 450 new medicines approved in the U.S. since 2000 to help fight cancer,...
Read More
Medicare Monday: Providing Value to Beneficiaries
By Allyson Funk | February 2, 2015
Medicare Part D is an incredibly important and successful program that provides seniors and persons with disabilities with access to affordable prescription drug coverage. While recent surveys...
Read More
Medicare Monday (100)
340B Spotlight (42)
Cost & Consequence (0)
